Palliative endoscopic biliary drainage for malignant hilar biliary obstruction

Area of Science:

• Gastroenterology
• Oncology
• Interventional Radiology

Background:

• Malignant hilar biliary obstruction (MHBO) presents with jaundice, pruritus, and cholangitis, impairing patient performance and delaying cancer treatment.
• Effective biliary drainage is crucial for palliation and enabling oncologic therapy in MHBO patients.

Purpose of the Study:

• To review current management strategies for malignant hilar biliary obstruction.
• To highlight the importance of biliary decompression for patient outcomes and treatment initiation.

Main Methods:

• Standard approach: Endoscopic transpapillary biliary stenting via ERCP.
• Stent choices: Plastic or self-expandable metal stents for unresectable disease.
• Alternative techniques: Percutaneous transhepatic or EUS-guided biliary drainage if transpapillary access fails.
• Adjunctive therapies: Photodynamic therapy and radiofrequency ablation are under investigation.

Main Results:

• Optimal drainage targets >50% functional liver volume, avoiding atrophic segments.
• Successful biliary decompression improves performance status and allows chemotherapy initiation.
• Ongoing research into adjunctive therapies aims to improve local tumor control and stent longevity.

Conclusions:

• Biliary drainage is essential for managing MHBO, improving patient condition for cancer treatment.
• Advances in stent technology and endoscopic techniques are leading to more personalized and effective MHBO management.
• Individualized treatment plans considering stent type, drainage volume, and adjunctive therapies are key for optimal outcomes.